Scientific Advisory Board

The Bluefield Scientific Advisory Board is composed of world-recognized leaders in clinical and basic research. They evaluate current research, advise on funding decisions and provide strategic advice in support of our mission to find a cure or treatment for frontotemporal dementia.

 

Steven B. Miller, M.D.*

Senior Vice President and Chief Medical Officer
Express Scripts, Inc.

DAVID HOLTZMAN, M.D.

Andrew B. and Gretchen P. Jones Professor and Chairman of Neurology
Professor of Developmental Biology
Associate Director of the Alzheimer's Disease Research Center
Washington University in St. Louis School of Medicine

David Knopman, M.D.

Professor of Neurology
Mayo Clinic, Minnesota

Kenneth S. Kosik, M.D.

Harriman Professor of Neuroscience
University of California, Santa Barbara

Ian Massey, Ph.D.

President and Chief Operating Officer
StemCells, Inc.

William C. Mobley, M.D., Ph.D.

Distinguished Professor and Chair, Department of Neurosciences
Executive Director of UCSD's Down Syndrome Center for Research and Treatment
University of California, San Diego

LaWrence Steinman, M.D.

Professor of Neurology and Neurological Sciences, Pediatrics, and Genetics
Stanford School of Medicine

 

 

 

*Chair